Delivery Order SPE2DB25D3020-SPE2DB25FWJVD
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg, a controlled-release pain management pharmaceutical. This non-set-aside, competitively awarded delivery order has a ceiling value of $15,791.14 and a firm fixed-price structure, with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,990.02 on August 6, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg to the Defense Logistics Agency's Medical Supply Chain. The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order...
- This delivery order, awarded on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides Oxymorphone HCL ER Tablets 40mg with a ceiling value of $2,062.57. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26 and an ultimate completion date of August 25, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Oxymorphone HCL ER Tablets 20mg, valued at $11,664.15 under a firm fixed-price contract type. This non-competitive delivery order represents a single-item pharmaceutical procurement with an ultimate completion date of August 21, 2025. The award was made without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Oxymorphone HCL ER 20 mg tablets (60-count packages) with a ceiling value of $2,869.54. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,198.34 to AmerisourceBergen Drug Corp for Oxymorphone HCL ER 20 mg tablets (60-count supply). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 2, 2025. The award was issued on August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg, with a contract ceiling value of $3,394.93 and an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania—the designated place of performance....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Oxymorphone HCL ER 20 mg tablets in quantities of 60 units, with a ceiling value of $3,548.65. This is a firm fixed-price delivery order executed under a non-competitive, non-set-aside procurement. The order is scheduled for completion by November 18, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,311.06 on September 22, 2025, for the supply of Oxymorphone HCL Extended Release tablets (20mg) under a Firm Fixed Price contract with the Defense Logistics Agency's Medical Supply Chain. The contract is a non-set-aside award issued through competitive procurement and carries an ultimate completion date of September 23, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken,...